ABCL — AbCellera Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for AbCellera Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	723	886	761	626	534
Net Total Accounts Receivable
Net Total Receivables	175	103	64.4	92.1	153
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	930	1,025	872	751	728
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	112	217	288	340	428
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,319	1,541	1,488	1,361	1,357
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	121	118	119	76.6	64.3
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	293	308	336	304	390
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,026	1,233	1,152	1,056	967
Total Liabilities & Shareholders' Equity	1,319	1,541	1,488	1,361	1,357
Total Common Shares Outstanding